 |
|
2004
Dr. Linda Buck, a member of the Hutchinson Center’s Basic Sciences Division, receives the Nobel Prize in physiology or medicine for her groundbreaking work in understanding the mechanisms of olfaction, or the sense of smell. Her discoveries open new doors to studying the brain and have numerous implications for health.
|
|
Linda Buck, Ph.D., Nobel Laureate, Physiology or Medicine
|
|
2001
The “mini-transplant” procedure, developed by the Hutchinson Center's researchers, is shown to be an effective, less-toxic therapy for treating blood cancers in patients over age 50.
|
|
|
|
2001
Dr. Lee Hartwell, president and director of the Hutchinson Center, is awarded the Nobel Prize in physiology or medicine for his discoveries regarding the mechanisms that control cell division in yeast. These same genes subsequently have been found to also control cell division in humans and often to be the site of alteration in cancer.
|
|
Lee Hartwell, Ph.D., Nobel Laureate, Physiology or Medicine
|
|
1997
The Hutchinson Center's investigators identify two cell-cycle proteins that influence breast-cancer outcome, paving the way for a new era of medicine that relies on molecular tests to predict cancer prognosis.
|
|
|
|
1992
The Hutchinson Center's clinical investigators are the first to show that monoclonal antibodies can be used to target high doses of radiotherapy to leukemia- and lymphoma-related tumors.
|
|
|
|
1991
First autologous peripheral stem-cell transplant is performed, in which stem cells are collected from the patient’s blood.
|
|
|
|
1990
Dr. E. Donnall Thomas, the founding director of the Hutchinson Center’s Clinical Research Division, receives the Nobel Prize in physiology or medicine for his pioneering work in bone-marrow transplantation for leukemia, lymphoma and other blood disorders.
|
|
E. Donnall Thomas, M.D., Nobel Laureate, Physiology or Medicine
|
|
1989
The Hutchinson Center's researchers develop gene-transfer technology used in the world’s first successful human gene-therapy trials conducted by the National Institutes of Health. Gene therapy continues to be one of the most promising approaches to treat cancer and other diseases for which no conventional therapy currently exists.
|
|
A peek inside a lab
|
|
1987
The National Marrow Donor Program, which links transplant patients with unrelated marrow donors, is established with the help of Dr. John Hansen and colleagues in the Hutchinson Center’s Clinical Research Division.
|
|
|
|
1982
The Cancer Prevention Research Program is established at the Hutchinson Center. Today it is the oldest and largest such program in the nation. Research milestones include the identification of significant associations between exercise and reduced cancer risk as well as nutrition and cancer prevention.
For example, the Hutchinson Center researchers found that eating at least three servings of vegetables a week lowers the risk of prostate cancer by nearly half, and engaging in regular aerobic activity three to four hours a week lowers the risk of breast cancer by up to 40 percent.
|
|
|
|
1980
First patient is successfully treated with autologous bone-marrow transplantation, in which the patient’s own marrow is used for treatment.
|
|
|
|
1979
First patient is successfully transplanted from an unrelated donor.
|
|
|
|
1976
World’s first pediatric bone-marrow transplant program is officially established at Fred Hutchinson Cancer Research Center.
|
|
|
|
1975
With the help of Washington state's legendary U.S. Senator Warren Magnuson and the Seattle community, federal and private funding led to the construction and opening of the Hutchinson Center in 1975.
|
|
Groundbreaking Ceremony for Fred Hutchinson Cancer Research Center with Dr. William Hutchinson (left) and Senator Warren Magnuson
|
|
1974
Dr. Robert Hickman inserts the first central intravenous catheter (later known as the Hickman line), revolutionizing the way that bone-marrow transplant recipients and other cancer patients receive intravenous infusions of chemotherapy and nutritional support.
|
|
|
|
1970
First non-Hodgkin’s lymphoma patient successfully treated with bone-marrow transplantation.
|
|
|
Back to top
|
